When.com Web Search

  1. Ads

    related to: alzheimer's clinical practice guidelines 2023

Search results

  1. Results From The WOW.Com Content Network
  2. NINCDS-ADRDA Alzheimer's Criteria - Wikipedia

    en.wikipedia.org/wiki/NINCDS-ADRDA_Alzheimer's...

    Similar to the NINCDS-ADRDA Alzheimer's Criteria are the DSM-IV-TR criteria published by the American Psychiatric Association. [3] At the same time the advances in functional neuroimaging techniques such as PET or SPECT that have already proven their utility to differentiate Alzheimer's disease from other possible causes, [4] have led to proposals of revision of the NINCDS-ADRDA criteria that ...

  3. Boston criteria - Wikipedia

    en.wikipedia.org/wiki/Boston_criteria

    Boston criteria. The Boston criteria version 2.0 [1] is a set of guidelines designed to diagnose cerebral amyloid angiopathy (CAA), a disease that affects small blood vessels in the brain, particularly those in the cortex and leptomeninges. Although the gold standard for diagnosis is histopathological examination, the Boston criteria provide ...

  4. Alzheimer's Research & Therapy - Wikipedia

    en.wikipedia.org/wiki/Alzheimer's_Research_&_Therapy

    Alzheimer's Research & Therapy is a peer-reviewed medical journal covering research on Alzheimer's disease. It is affiliated with (Alzheimer's research UK). It was established in 2009 and is published by BioMed Central. The editors-in-chief are Delphine Boche (University of Southampton), Miia Kivipelto (Karolinska Institute), and Charlotte ...

  5. Biomarkers of Alzheimer's disease - Wikipedia

    en.wikipedia.org/wiki/Biomarkers_of_Alzheimer's...

    The biomarkers can be used to diagnose Alzheimer's disease (AD) in a very early stage, but they also provide objective and reliable measures of disease progress. It is imperative to diagnose AD disease as soon as possible, because neuropathologic changes of AD precede the symptoms by years. [1] It is well known that amyloid beta (Aβ) is a good ...

  6. ADAS-Cog - Wikipedia

    en.wikipedia.org/wiki/ADAS-Cog

    ADAS-Cog. The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog) is a brief neuropsychological assessment used to assess the severity of cognitive symptoms of dementia. It is one of the most widely used cognitive scales in clinical trials [1] and is considered to be the “gold standard” for assessing antidementia treatments.

  7. Dementia - Wikipedia

    en.wikipedia.org/wiki/Dementia

    Dementia is a syndrome associated with many neurodegenerative diseases, characterized by a general decline in cognitive abilities that affects a person's ability to perform everyday activities. This typically involves problems with memory, thinking, behavior, and motor control. [10]